Dual Targeting EGFR and STAT3 With Erlotinib and Alantolactone Co-Loaded PLGA Nanoparticles for Pancreatic Cancer Treatment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual Targeting EGFR and STAT3 With Erlotinib and Alantolactone Co-Loaded PLGA Nanoparticles for Pancreatic Cancer Treatment
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-19
DOI
10.3389/fphar.2021.625084
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Localized Controlled Release of Bilirubin from β-Cyclodextrin-Conjugated ε-Polylysine To Attenuate Oxidative Stress and Inflammation in Transplanted Islets
- (2020) Qing Yao et al. ACS Applied Materials & Interfaces
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Dynamic ROS Control by TIGAR Regulates the Initiation and Progression of Pancreatic Cancer
- (2020) Eric C. Cheung et al. CANCER CELL
- Endocytosis of ATB0,+(SLC6A14)-targeted liposomes for drug delivery and its therapeutic application for pancreatic cancer
- (2020) Longfa Kou et al. Expert Opinion on Drug Delivery
- Combined Src/EGFR Inhibition Targets STAT3 Signaling and Induces Stromal Remodeling to Improve Survival in Pancreatic Cancer
- (2020) Austin R. Dosch et al. MOLECULAR CANCER RESEARCH
- The role of transporters in cancer redox homeostasis and cross-talk with nanomedicines
- (2020) Longfa Kou et al. Asian Journal of Pharmaceutical Sciences
- Tumor microenvironment-responsive multistaged liposome induces apoptosis and ferroptosis by amplifying oxidative stress for enhanced cancer therapy
- (2020) Longfa Kou et al. ACS Applied Materials & Interfaces
- Evolution from small molecule to nano-drug delivery systems - An emerging approach for cancer therapy of ursolic acid
- (2020) Jingwei Shao et al. Asian Journal of Pharmaceutical Sciences
- Development of Promitil®, a lipidic prodrug of mitomycin c in PEGylated liposomes: From bench to bedside
- (2020) Alberto Gabizon et al. ADVANCED DRUG DELIVERY REVIEWS
- Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies
- (2020) Farshad Moradi Kashkooli et al. JOURNAL OF CONTROLLED RELEASE
- Bilirubin Protects Transplanted Islets by Targeting Ferroptosis
- (2020) Qing Yao et al. Frontiers in Pharmacology
- Nanoparticle mediated codelivery of nifuratel and doxorubicin for synergistic anticancer therapy through STAT3 inhibition
- (2020) Hailun Zheng et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Silk Fibroin-Modified Disulfiram/Zinc Oxide Nanocomposites for pH Triggered Release of Zn2+ and Synergistic Antitumor Efficacy
- (2020) Ying-Zheng Zhao et al. MOLECULAR PHARMACEUTICS
- Hypoxia-activated ROS burst liposomes boosted by local mild hyperthermia for photo/chemodynamic therapy
- (2020) Xiang-long Tang et al. JOURNAL OF CONTROLLED RELEASE
- Tumor microenvironment-responsive and oxygen self-sufficient oil droplet nanoparticles for enhanced photothermal/photodynamic combination therapy against hypoxic tumors
- (2020) Reesha Kv et al. JOURNAL OF CONTROLLED RELEASE
- Alantolactone promotes ER stress-mediated apoptosis by inhibition of TrxR1 in triple-negative breast cancer cell lines and in a mouse model
- (2019) Changtian Yin et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)
- (2019) Thorvardur R. Halfdanarson et al. ONCOLOGIST
- Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAF
- (2019) María Teresa Blasco et al. CANCER CELL
- Ambidextrous Approach To Disrupt Redox Balance in Tumor Cells with Increased ROS Production and Decreased GSH Synthesis for Cancer Therapy
- (2019) Longfa Kou et al. ACS Applied Materials & Interfaces
- Targeting non-oncogene ROS pathway by alantolactone in B cell acute lymphoblastic leukemia cells
- (2019) Xiaoguang Xu et al. LIFE SCIENCES
- The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice
- (2019) Dannielle D. Engle et al. SCIENCE
- Sodium cantharidate targets STAT3 and abrogates EGFR inhibitor resistance in osteosarcoma
- (2019) Xiang lu Ji et al. Aging-US
- Oxidation-strengthened disulfide-bridged prodrug nanoplatforms with cascade facilitated drug release for synergetic photochemotherapy
- (2019) Bin Yang et al. Asian Journal of Pharmaceutical Sciences
- Berbamine Enhances the Efficacy of Gefitinib by Suppressing STAT3 Signaling in Pancreatic Cancer Cells
- (2019) Bingren Hu et al. OncoTargets and Therapy
- ROS mediated EGFR/MEK/ERK/HIF-1α Loop Regulates Glucose metabolism in pancreatic cancer
- (2018) Gang Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- IL-22RA1/ STAT3 signaling promotes stemness and tumorigenicity in pancreatic cancer
- (2018) Weizhi He et al. CANCER RESEARCH
- MMP-Responsive ‘Smart’ Drug Delivery and Tumor Targeting
- (2018) Qing Yao et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase
- (2018) Jiang-Kai Dong et al. Theranostics
- Targeting S1PR1/STAT3 loop abrogates desmoplasia and chemosensitizes pancreatic cancer to gemcitabine
- (2018) Manendra Babu Lankadasari et al. Theranostics
- Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types
- (2018) Longfa Kou et al. Frontiers in Pharmacology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer
- (2018) Nagaraj S Nagathihalli et al. CANCER RESEARCH
- Intestinal Absorption of Isoalantolactone and Alantolactone, Two Sesquiterpene Lactones from Radix Inulae, Using Caco-2 Cells
- (2018) Renjie Xu et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Delivery of docetaxel using pH-sensitive liposomes based on D-?-tocopheryl poly(2-ethyl-2-oxazoline) succinate: comparison with PEGylated liposomes
- (2018) Shu Hana et al. Asian Journal of Pharmaceutical Sciences
- Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling
- (2018) Hailun Zheng et al. MOLECULAR CARCINOGENESIS
- Modulating intestinal mucus barrier for nanoparticles penetration by surfactants
- (2018) Xin Zhang et al. Asian Journal of Pharmaceutical Sciences
- CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial
- (2017) Marianne Sinn et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficient Codelivery of Paclitaxel and Curcumin by Novel Bottlebrush Copolymer-based Micelles
- (2017) Qing Yao et al. MOLECULAR PHARMACEUTICS
- Cotransporting Ion is a Trigger for Cellular Endocytosis of Transporter-Targeting Nanoparticles: A Case Study of High-Efficiency SLC22A5 (OCTN2)-Mediated Carnitine-Conjugated Nanoparticles for Oral Delivery of Therapeutic Drugs
- (2017) Longfa Kou et al. Advanced Healthcare Materials
- Feedback Activation of STAT3 as a Cancer Drug-Resistance Mechanism
- (2016) Chengguang Zhao et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells
- (2015) Jaemoo Chun et al. CANCER LETTERS
- Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer
- (2015) Wei Wen et al. Molecular Cancer
- Targeting Epidermal Growth Factor Receptor–Related Signaling Pathways in Pancreatic Cancer
- (2015) Philip A. Philip et al. PANCREAS
- Hydrogen peroxide sensing, signaling and regulation of transcription factors
- (2014) H. Susana Marinho et al. Redox Biology
- Alantolactone inhibits growth of K562/adriamycin cells by downregulating Bcr/Abl and P-glycoprotein expression
- (2013) Chunhui Yang et al. IUBMB LIFE
- The quest to overcome resistance to EGFR-targeted therapies in cancer
- (2013) Curtis R Chong et al. NATURE MEDICINE
- Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells
- (2013) Atsushi Sato et al. Stem Cell Research
- The endocytosis and intracellular fate of nanomedicines: Implication for rational design
- (2013) Longfa Kou et al. Asian Journal of Pharmaceutical Sciences
- Role of ATP-Binding Cassette and Solute Carrier Transporters in Erlotinib CNS Penetration and Intracellular Accumulation
- (2010) M. A. Elmeliegy et al. CLINICAL CANCER RESEARCH
- Endocytosis of nanomedicines
- (2010) Gaurav Sahay et al. JOURNAL OF CONTROLLED RELEASE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started